You are here: Industry Insights > Dexamethasone

News List

Genmab/Janssen’s Darzalex combo hits the mark in phase 3 study pharmatimes
August 04, 2020
Genmab and Janssen’s subcutaneous formulation of Darzalex (daratumumab) in combination with pomalidomide and dexamethasone (Pd) has generated positive results in a phase 3 myeloma trial.
EMA initiates review of dexamethasone for treating COVID-19 europeanpharmaceuticalreview
July 29, 2020
The EMA has begun to review dexamethasone to provide an opinion on the results of the RECOVERY study for the treatment of adults admitted to hospital with COVID-19.
Japan approves dexamethasone to treat Covid-19 patients pharmaceutical-technology
July 23, 2020
The Japanese health ministry has approved a low-cost and widely available steroid drug, dexamethasone, for the treatment of patients suffering from Covid-19.
Dexamethasone’s COVID-19 benefits confirmed; spotlight on immune cells expresspharma
July 20, 2020
The full results of a large randomized clinical trial in Britain looking at the steroid dexamethasone confirmed the benefits in its use in COVID-19 patients that were hinted at in early findings issued last month.
Dexamethasone added to COVID-19 treatment protocol expresspharma
June 28, 2020
The Union Ministry of Health & Family Welfare released an updated clinical management protocol for managing COVID-19 cases which advises the use of Dexamethasone as an alternative choice to Methylprednisolone to manage moderate to severe cases of COVID-19
Dexamethasone to be available on NHS as COVID-19 treatment europeanpharmaceuticalreview
June 23, 2020
The UK government has approved dexamethasone to be available on the NHS, following clinical trials proving its efficacy at reducing the risk of death for COVID-19 patients.
UK approves dexamethasone for Covid-19 patients after positive data pharmaceutical-technology
June 18, 2020
The UK Government has authorised the use of anti-inflammatory drug dexamethasone for the treatment of Covid-19 on the National Health Service (NHS), immediately after the report of positive data from the RECOVERY trial.
WHO moves to update COVID-19 guidance after ‘great news’ in dexamethasone study expresspharma
June 18, 2020
Trial results announced showed dexamethasone, used since the 1960s to reduce inflammation in diseases such as arthritis, cut death rates by around a third among the most severely ill COVID-19 patients admitted to hospital.
Dexamethasone, low cost steroid drug can reduce COVID-19 mortality expresspharma
June 17, 2020
Hailing it is a ‘major breakthrough’, researchers claim that this medicine reduced death rates by around a third among the most severely ill COVID-19 patients admitted to hospital.
Novel Therapy Treats Triple-Class Refractory Multiple Myeloma drugs
August 26, 2019
The combination of selinexor and dexamethasone seems effective in treating patients with multiple myeloma that has not responded to standard therapies...

Previous page 1 2 3 4 Next page